99% Savings - Buy Just @1 Rs X
Quikhale SF 250 mcg Capsule, a prescription drug, is manufactured in various forms such as Capsule. The alternative uses of Quikhale SF 250 mcg Capsule have also been explained below.
The correct dosage of Quikhale SF 250 mcg Capsule depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Quikhale SF 250 mcg Capsule are Shortness of Breath, Throat Irritation, Nosebleed. While these are the most often observed Quikhale SF 250 mcg Capsule side effects, there are can be others also. These have been listed below. These side effects of Quikhale SF 250 mcg Capsule are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Quikhale SF 250 mcg Capsule's effect is Moderate during pregnancy and Mild for lactating mothers. It is important to know if Quikhale SF 250 mcg Capsule has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Quikhale SF 250 mcg Capsule related warnings section.
Some other conditions that can be affected by Quikhale SF 250 mcg Capsule are listed in the contraindications section below.
Drug reaction of Quikhale SF 250 mcg Capsule with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Quikhale SF 250 mcg Capsule, it is important to know that it is safe while driving, and is habit-forming.
Quikhale SF 250 mcg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Quikhale SF 250 mcg Capsule safe for pregnant women?
Quikhale SF can have harmful effects in pregnant women. If you experience any discomfort after using Quikhale SF, then discontinue the use and take your doctor's advice.
Is the use of Quikhale SF 250 mcg Capsule safe during breastfeeding?
Quikhale SF may have very limited harmful effects for breastfeeding women.
What is the effect of Quikhale SF 250 mcg Capsule on the Kidneys?
Quikhale SF does not damage the kidneys.
What is the effect of Quikhale SF 250 mcg Capsule on the Liver?
You may experience side effects on your liver after taking Quikhale SF. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Quikhale SF 250 mcg Capsule on the Heart?
Quikhale SF can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Quikhale SF 250 mcg Capsule unless your doctor advises you to do so -
Is this Quikhale SF 250 mcg Capsule habit forming or addictive?
Quikhale SF 250 mcg Capsule does not cause addiction.
Interaction between Food and Quikhale SF 250 mcg Capsule
Due to the absence of research, it is difficult to say how Quikhale SF 250 mcg Capsule and food will interact.
Interaction between Alcohol and Quikhale SF 250 mcg Capsule
Due to lack of research, there is no information about the side effects of taking Quikhale SF 250 mcg Capsule with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359